Moreover, the result showed that, subjects carrying both null GSTT1 and GSTM1 genotypes had higher risk of hematological disorders compared to subjects with both positive GSTT1 and GSTM1 genotypes (OR = 2.35, CI = 1.14–4.8). This evidence concerns the gene GSTM1 and hematologic disorder.